Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma - A Real-World Experience.
Cancer Manag Res
; 13: 7139-7148, 2021.
Article
in En
| MEDLINE
| ID: mdl-34548818
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancer Manag Res
Year:
2021
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Nueva Zelanda